Loading organizations...
Key people at RightHill Ventures.
RightHill Ventures operates as a venture capital firm, investing in early-stage technology companies. It specializes in commercializing promising research and development directly from university settings, bridging academic innovation and market viability. The firm provides investment capital and strategic support, transforming intellectual property into high-growth commercial enterprises.
The firm's inception stemmed from the untapped commercial potential of university research, supported by a U.S. Economic Development Administration grant. Thorne Sparkman was key in leading this specialized fund's formation, addressing the need to transition academic discoveries into successful market ventures. This foundational effort created a dedicated pathway for scholarly innovation.
RightHill Ventures supports founders and emerging technology companies from higher education institutions. Its mission involves nurturing these ventures with essential resources and strategic partners, guiding their journey from scientific concept to market-ready product. The firm envisions an ecosystem where academic breakthroughs consistently translate into impactful, commercially successful solutions.
Key people at RightHill Ventures.
RightHill Ventures has 3 tracked investments across 3 companies. The latest tracked deal is $10.2M Series A Extension in MindImmune Therapeutics in November 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 24, 2025 | MindImmune Therapeutics | $10.2M Series A Extension | Reetika Bhardwaj | Foundation For A Better World, Gates Frontier, Slater Technology Fund |
| Dec 1, 2023 | Lenoss Medical | $4.0M Series A | — | Xcellerant Ventures, Highpoint Ventures, Vodia Ventures |
| Apr 21, 2023 | VoltServer | $17.5M Series B | Jorge Acevedo, Marker Hill Capital | Clean Energy Venture Group, Norman Adkins |